Hepatitis B Surface Antigens
"Hepatitis B Surface Antigens" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Those hepatitis B antigens found on the surface of the Dane particle and on the 20 nm spherical and tubular particles. Several subspecificities of the surface antigen are known. These were formerly called the Australia antigen.
| Descriptor ID |
D006514
|
| MeSH Number(s) |
D23.050.327.495.500.475
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Hepatitis B Surface Antigens".
Below are MeSH descriptors whose meaning is more specific than "Hepatitis B Surface Antigens".
This graph shows the total number of publications written about "Hepatitis B Surface Antigens" by people in this website by year, and whether "Hepatitis B Surface Antigens" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1996 | 0 | 1 | 1 |
| 2003 | 1 | 1 | 2 |
| 2005 | 1 | 0 | 1 |
| 2006 | 0 | 1 | 1 |
| 2013 | 0 | 1 | 1 |
| 2020 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Hepatitis B Surface Antigens" by people in Profiles.
-
Hepatitis B reactivation in patients on biologics: A perfect storm. J Am Acad Dermatol. 2022 01; 86(1):37-38.
-
Characteristics of amino acid substitutions within the "a" determinant region of hepatitis B virus in chronically infected patients with coexisting HBsAg and anti-HBs. Clin Res Hepatol Gastroenterol. 2020 11; 44(6):923-931.
-
Characterization of HIV-HBV coinfection in a multinational HIV-infected cohort. AIDS. 2013 Jan 14; 27(2):191-201.
-
Does rapid oligomerization of hepatitis B envelope proteins play a role in resistance to proteasome degradation and enhance chronicity? DNA Cell Biol. 2006 Mar; 25(3):165-70.
-
Extended lamivudine treatment in patients with HBeAg-negative chronic hepatitis B. J Hepatol. 2005 Feb; 42(2):173-9.
-
Durability of serologic response after lamivudine treatment of chronic hepatitis B. Hepatology. 2003 Apr; 37(4):748-55.
-
Histological outcome during long-term lamivudine therapy. Gastroenterology. 2003 Jan; 124(1):105-17.
-
Amplification of full-length hepatitis B virus genomes from samples from patients with low levels of viremia: frequency and functional consequences of PCR-introduced mutations. J Clin Microbiol. 1998 Feb; 36(2):531-8.
-
A program for eradication of hepatitis B from Taiwan by a 10-year, four-dose vaccination program. Cancer Causes Control. 1996 May; 7(3):305-11.
-
The prevalence of hepatitis C in a regional level I trauma center population. J Trauma. 1992 Jul; 33(1):126-8; discussion 128-9.